Substantial decreases in the number and diversity of microbiota during chemotherapy-induced gastrointestinal mucositis in a rat model

Margot Fijlstra, Mithila Ferdous, Anne M Koning, Edmond H H M Rings, Hermie J M Harmsen, Wim J E Tissing

Research output: Contribution to journalArticlepeer-review

64 Citations (Scopus)


PURPOSE: Earlier, we showed in acute myeloid leukemia (AML) patients that the microbiota changes dramatically during anticancer treatment, coinciding with gastrointestinal mucositis: The commensal anaerobic populations reduce in favor of potential pathogens. Therefore, interventions targeting the microbiota during mucositis might be interesting but can better be tested in animals than in vulnerable mucositis patients. Here, we aimed to study the potential microbial changes during methotrexate (MTX)-induced gastrointestinal mucositis in a well-established rat model and to study whether this model can be used for future microbial intervention studies.

METHODS: After injection with MTX or saline (day 0), rats were sacrificed between days 2 and 11. Plasma citrulline level, jejunal histology, and the number and diversity of intestinal bacteria in feces (using fluorescence in situ hybridization (FISH)) were determined.

RESULTS: Mucositis was most severe on day 4 when food intake, plasma citrulline, and villus length were the lowest, compared with controls (P < 0.0125). At the same time, MTX-treated rats showed an overall decrease (705-fold) in most bacteria (using a universal probe), compared with controls (P < 0.125). Reduced bacterial presence was related with the presence of diarrhea and a reduced villus length (rho = 0.38, P < 0.05). At day 4, there was an absolute and relative decrease of anaerobes (13-fold and -58 %, respectively) and streptococci (296-fold and -1 %, respectively) but a relative increase of Bacteroides (+49 %), compared with controls (P < 0.125).

CONCLUSIONS: In the mucositis rat model, we found substantial decreases in the number and diversity of microbiota, resembling earlier findings in humans. The model therefore seems well suited to study the effects of different microbial interventions on mucositis, prior to performing human studies.

Original languageEnglish
Pages (from-to)1513-22
Number of pages10
JournalSupportive Care in Cancer
Issue number6
Publication statusPublished - Jun 2015
Externally publishedYes


  • Animals
  • Citrulline/blood
  • In Situ Hybridization, Fluorescence
  • Intestinal Mucosa/drug effects
  • Male
  • Methotrexate/adverse effects
  • Microbiota/drug effects
  • Mucositis/blood
  • Random Allocation
  • Rats
  • Rats, Wistar


Dive into the research topics of 'Substantial decreases in the number and diversity of microbiota during chemotherapy-induced gastrointestinal mucositis in a rat model'. Together they form a unique fingerprint.

Cite this